<b>Conclusions</b>: HDAC-2 expression may have clinicopathological relevance in CRC, particularly in relation to recurrence-related outcomes, although larger studies are needed to confirm its prognostic significance. This evidence concerns the gene HDAC2 and colorectal carcinoma.